RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $387,456 | -1.5% | 46,013 | +46.7% | 0.00% | +100.0% |
| Q2 2023 | $393,506 | -12.9% | 31,368 | +14.5% | 0.00% | -50.0% |
| Q1 2023 | $451,590 | -28.3% | 27,394 | -33.5% | 0.00% | +100.0% |
| Q4 2022 | $629,979 | +21.6% | 41,199 | +77.6% | 0.00% | -50.0% |
| Q3 2022 | $518,000 | +14.1% | 23,200 | -14.4% | 0.00% | 0.0% |
| Q2 2022 | $454,000 | +44.1% | 27,102 | +157.7% | 0.00% | +100.0% |
| Q1 2022 | $315,000 | -2.5% | 10,516 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $323,000 | +31.3% | 10,516 | +35.0% | 0.00% | 0.0% |
| Q3 2021 | $246,000 | +15.5% | 7,789 | +33.6% | 0.00% | 0.0% |
| Q2 2021 | $213,000 | +5.4% | 5,830 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $202,000 | -5.6% | 5,830 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $214,000 | -2.3% | 5,140 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $219,000 | – | 5,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |